Li Li
Vermögen: 3 Mio $ am 31.05.2026
Vermögen: 3 Mio $ am 31.05.2026
Li Li is currently a Non-Executive Director at Shandong Boan Biotechnology Co., Ltd., a Director at Shandong Asj Biotechnology Co. Ltd., and a Director at Guangzhou Patronus Biotechnology Co. Ltd. Ms. Li's former position was as a Vice President at Luye Pharma Group Ltd. Ms. Li holds a Master's in Business Administration from China Europe International Business School and an undergraduate degree from Yantai University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.06.2025 | 3.500.000 ( 0,56 % ) | 3 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| SHANDONG BOAN BIOTECHNOLOGY CO., LTD. | Direktor/Vorstandsmitglied | 22.06.2020 |
Shandong Asj Biotechnology Co. Ltd. | Direktor/Vorstandsmitglied | 01.02.2020 |
Guangzhou Patronus Biotechnology Co. Ltd. | Direktor/Vorstandsmitglied | 01.11.2020 |
| Unternehmen | Position | Ende |
|---|---|---|
| LUYE PHARMA GROUP LTD. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
China Europe International Business School
China Europe International Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Luye Pharma Group Ltd.
Luye Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Yantai University
Yantai University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shandong Boan Biotechnology Co., Ltd.
Shandong Boan Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies for oncology, immunology, pain and endocrine diseases | Health Technology |
Shandong Asj Biotechnology Co. Ltd. | |
Guangzhou Patronus Biotechnology Co. Ltd. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen